This reduction in intracellular cholesterol enhances IL-4 receptor (IL-4R)/STAT6/PI3K signaling in vitro and in vivo, promoting the expression of the typical M2 marker arginase-1 while inhibiting NOS2 and proinflammatory IL-12 expression, thereby promoting tumor progression [309, 310]. Here, IL4R is linked to neoplasm.